Distribuzione geografica
Continente #
EU - Europa 30
NA - Nord America 8
Totale 38
Nazione #
IT - Italia 28
US - Stati Uniti d'America 8
FR - Francia 2
Totale 38
Città #
Salerno 23
Fisciano 2
Fleming Island 2
Paris 2
Milan 1
Naples 1
Santa Clara 1
Totale 32
Nome #
The pharmaceutical device prisma® skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing, file e2915b32-9dab-8981-e053-6605fe0a83a3 4
Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System, file e2915b33-9417-8981-e053-6605fe0a83a3 4
The procoagulant activity of emoxilane®: A new appealing therapeutic use in epistaxis of the combination of sodium hyaluronate, silver salt, α-tocopherol and d-panthenol, file e2915b35-544e-8981-e053-6605fe0a83a3 4
The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk, file ab8656bc-4d71-4b8c-be59-5c4c415401f7 3
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells., file e2915b31-3db9-8981-e053-6605fe0a83a3 3
Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing, file e2915b31-288c-8981-e053-6605fe0a83a3 2
miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing, file e2915b33-5e1c-8981-e053-6605fe0a83a3 2
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2, file e2915b34-c968-8981-e053-6605fe0a83a3 2
Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors, file e2915b35-0f1d-8981-e053-6605fe0a83a3 2
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics, file e2915b35-4dc3-8981-e053-6605fe0a83a3 2
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid, file e2915b31-8f30-8981-e053-6605fe0a83a3 1
Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness, file e2915b32-9b90-8981-e053-6605fe0a83a3 1
Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts, file e2915b33-5ece-8981-e053-6605fe0a83a3 1
Mesoglycan induces keratinocyte activation by triggering syndecan‐4 pathway and the formation of the annexin A1/S100A11 complex, file e2915b33-b94e-8981-e053-6605fe0a83a3 1
Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs, file e2915b33-bf97-8981-e053-6605fe0a83a3 1
PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation, file e2915b33-e56f-8981-e053-6605fe0a83a3 1
Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing, file e2915b33-eb8c-8981-e053-6605fe0a83a3 1
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway, file e2915b34-b2e9-8981-e053-6605fe0a83a3 1
Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells, file e2915b34-f4d5-8981-e053-6605fe0a83a3 1
Plant hairy roots for the production of extracellular vesicles with antitumor bioactivity, file f1c423ef-729e-43fd-9ae3-436a7b5f3618 1
Totale 38
Categoria #
all - tutte 101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0010 00 00 0000
2020/202119 0000 00 170 1001
2022/202316 2002 03 81 0000
Totale 38